Clinical Trial Update: IXO+A in mCRC With Liver-only Metastases [Phase 2]

View source ↗

Summary

A Phase 2 trial of IXO+A for metastatic colorectal cancer with liver-only metastases has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• IXO+A

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: WITHDRAWN